Rebecca Arend, Christine M. Lee, Charles K. Anderson, Krista Pfaendler, Peter Lim, Sonali Pandya, Mingwei Fei, Erin Saks. "A single-arm, phase 2 study of neoadjuvant mirvetuximab soravtansine and carboplatin for FRα-expressing advanced-stage serous epithelial ovarian, fallopian tube, or primary peritoneal cancer (M25-231; NCT06890338; GOG-3115).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps5633